NM_004463.3(FGD1):c.395G>A (p.Arg132Gln) AND Aarskog syndrome
- Germline classification:
- Likely benign (3 submissions)
- Last evaluated:
- Aug 11, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000608756.11
Allele description [Variation Report for NM_004463.3(FGD1):c.395G>A (p.Arg132Gln)]
NM_004463.3(FGD1):c.395G>A (p.Arg132Gln)
Condition(s)
- Name:
- Aarskog syndrome (AAS)
- Synonyms:
- FGDY; Aarskog Scott syndrome; Aarskog disease; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0010589; MedGen: C0175701; Orphanet: 915; OMIM: 305400
-
ras and Rab interactor 2 isoform X4 [Homo sapiens]
ras and Rab interactor 2 isoform X4 [Homo sapiens]gi|2462580560|ref|XP_054179514.1|Protein
-
Senecio serra internal transcribed spacer 1, partial sequence
Senecio serra internal transcribed spacer 1, partial sequencegi|8132478|gb|AF161641.1|Nucleotide
-
Chain A, HUMAN REGULATED UPON ACTIVATION NORMAL T-CELL EXPRESSED AND SECRETED
Chain A, HUMAN REGULATED UPON ACTIVATION NORMAL T-CELL EXPRESSED AND SECRETEDgi|2200752795|pdb|1HRJ|AProtein
-
OMIM Links for Nucleotide (Select 1890346383) (6)
OMIM
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024